Top Story

VIDEO: Surgeon reports 2-year data on the COMPASS trial

May 28, 2016

MILAN — At the OSN Italy meeting, E. Randy Craven, MD, discusses minimally invasive glaucoma surgery focusing on the 2-year results of the COMPASS trial on the CyPass micro-stent from Transcend Medical, as well as methods of sustained IOP reduction with an implantable drug delivery system.

Meeting News CoverageFrom OSN Europe

Combination of vitrectomy, penetrating keratoplasty stabilizes visual acuity

May 27, 2016
COLORADO SPRINGS, Colo. — Combined pars plana vitrectomy and penetrating keratoplasty stabilized visual acuity but yielded only modest visual gains, according to a…
Meeting News Coverage

New trifocal IOL shows good results in hyperopic patients

May 27, 2016
MILAN — Improvements have been made to the new trifocal Alcon AcrySof PanOptix IOL so that intermediate vision is better with a higher visual quality compared with…
Meeting News CoverageVideo

VIDEO: Screening patients for multifocal IOLs to optimize performance

May 27, 2016
MILAN — At OSN Italy, Jay Pepose, MD, PhD, gives advice on how to screen patients for multifocal IOLs in order to optimize performance and make “a…

Visual cycle modulator fails to meet primary endpoint of reducing GA growth rate

May 27, 2016
Acucela announced that the novel investigational visual cycle modulator emixustat hydrochloride failed to reduce geographic atrophy lesion growth rate in the SEATTLE…
More News Headlines »
Original Article

A New Surgical Treatment Option for Chronic Total Oculomotor Nerve Palsy: A Modified Technique for Medial Transposition of Split Lateral Rectus Muscle

Journal of Pediatric Ophthalmology and Strabismus, May/June 2016, Volume 53 Issue 3
To describe a new surgical modified procedure in patients with chronic total oculomotor nerve palsy and to evaluate the…
More »

Emerging Options for Day-in and Day-out IOP Control

This activity is supported by an educational grant from Bausch + Lomb.

Unfortunately, even with appropriate use of currently available medications, many people with glaucoma will still…
More »
Highlights from ASCRS

Highlights from ASCRS

Meeting News Coverage

VIDEO: Surgeon presents phase 3 clinical trial results of Rhopressa

May 24, 2016
More »